Ethyl 1-(4-methoxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate 99%
Price | Get Latest Price | ||||
Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:1MT
- Time:2024-02-21
Product Details
- Product NameEthyl 1-(4-methoxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate
- CAS No.503614-91-3
- EINECS No.700-890-7
- MFC27H28N4O5
- MW488.54
- AppearanceSolidWhite to Pale Beige
- density 1.34
- Boiling point 758.7±60.0 °C(Predicted)
- storage temp. Sealed in dry,Room Temperature
- Melting point 175 - 180°C
Company Profile Introduction
Glyra Healthcare Private Limited is a Private company incorporated on 16 January 2018. It is classified as Non-government company and is registered at Registrar of Companies, Ahmedabad. Its authorized share capital is Rs. 100,000 and its paid up capital is Rs. 100,000. It's NIC code is 519 (which is part of its CIN). As per the NIC code, it is inolved in Other wholesale [Includes specialized wholesale not covered in any one of the previous categories and wholesale in a variety of goods without any particular specialization.].
Glyra Healthcare's Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 31 March 2023.
Directors of Glyra Healthcare are BHAVESHKUMAR NATHANI RANCHHODBHAI and BHAVISHABEN BHAVESHKUMAR NATHANI.
Glyra Healthcare's Corporate Identification Number (CIN) is U51909GJ2018PTC100558 and its registration number is 100558. Users may contact Glyra Healthcare on its Email address - BHAVESH.NATHANI@GLYRAHEALTHCARE.COM. Registered address of Glyra Healthcare is 1137/1, MELDI ESTATE, NR. MELDI MATA TEMPLE, NR. RAILWAY CROSSING, , Gandhinagar, Gujarat, India - 382481.
Supplier other products
Recommended supplier
-
VIP1年
- LOBERAN PHARMA
- 503614-91-3 1-(4-Methoxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester > 99
- Inquiry
- 2024-11-14
-
VIP1年
- Scimplify
- 503614-91-3 99%
- Inquiry
- 2024-10-25
-
VIP1年
- VRUDDISRI PHARMA
- ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1- yl) phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c] pyridine-3 - carboxylate 503614-91-3 98% to 99%
- Inquiry
- 2024-05-06
-
VIP1年
- ADAARSH PHARMA
- Ethyl 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxopiperidin-1-Yl) Phenyl)-4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine-3-Carboxylate 503614-91-3 99%
- Inquiry
- 2024-05-03
-
VIP1年
- ACTIVZ LIFE SCIENCES (I) PVT LTD
- Ethyl 1-(4-methoxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate 503614-91-3 98%
- Inquiry
- 2024-03-11
-
VIP1年
- Mekong pharmaceuticals pvt ltd
- Ethyl 1-(4-methoxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate 503614-91-3 98%
- Inquiry
- 2024-03-02
-
VIP1年
- Cubane Pharmaceuticals LLP
- 503614-91-3 99%
- Inquiry
- 2024-02-08
- Since:2020-02-01
- Address: 43/A, Meldi Estate, B/H. West Cost Pharmaceuticals ltd. Nr. Gota Over Bridge, Gota, Ahmedabad, Gujar